Abbott Splits Company with AbbVie Spinout
January 02, 2013
Abbott Splits Company with AbbVie Spinout
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - MDx/CDx Focus: Abbott, Epizyme Advance CDx for Novel Leukemia Drug; Segeene, Selventa Develop MDx
April 24, 2013 / Pharmacogenomics Reporter - Abbott to Develop Companion Dx for Epizyme Cancer Drug Candidate
April 18, 2013 / GenomeWeb Daily News - Abbott Posts 1 Percent Gain for MDx Sales in Q1
April 17, 2013 / GenomeWeb Daily News - Abbott Receives EU CE Mark for Automated Version of BG Medicine's Galectin-3 Test
April 12, 2013 / ProteoMonitor